BOCA RATON, Fla., April 24 /PRNewswire-FirstCall/ -- Eclipsys Corporation® (Nasdaq: ECLP - News), The Outcomes Company®, today announced that PowerBANK Enterprise Edition recently received 510K Clearance from the Food and Drug Administration (FDA), meaning that it may be marketed for use by hospitals in the United States. PowerBANK Enterprise Edition is Eclipsys’ solution for automating the functions of a hospital’s blood bank and is a component of Eclipsys Sunrise Laboratory, a laboratory information solution (LIS) that helps increase productivity and decrease costs, providing efficient workflow and data management.
“With the availability of PowerBANK Enterprise Edition, Eclipsys now provides an easy-to-use solution that enables hospitals to completely automate blood bank operations,” said Jay Deady, Eclipsys executive vice president, Client Solutions. “This is an important step towards achieving Eclipsys goal of expanding our industry-leading solution portfolio to meet the needs of all hospital departments where information technology can help improve outcomes in care, cost, and satisfaction.”
Enables More Efficient Blood Bank Operations
PowerBANK Enterprise Edition enables more efficient management of a hospital’s blood bank operations by automating the processes from receipt of blood products to monitoring blood products and patient results as well as issue and transfusion documentation. The solution provides functionality for complete product inventory management and includes reports capabilities on receipt, release and results of blood products.
PowerBANK Enterprise Edition’s cross matching functionality enables users to enter results from a variety of mandatory tests to ensure product compatibility with the patient. The department may also use serologic or electronic cross matching procedures based on logics using historical patient information. Users are also able to manage the delivery and transfusion data collection for auditing of the blood product. PowerBANK Enterprise Edition is also available in Canada where West Parry Sound Health Centre (WPSHC), Parry Sound, Ontario, is using the solution to achieve improved management of its blood bank operations. Said Rhonda Borchardt, Manager of Laboratory Services at WPSHC, “PowerBANK Enterprise Edition does a great job helping us manage our blood bank. We know exactly what units of blood patients have received along with any other non-blood products and we know their complete history without having to search through an index. From a patient management standpoint it’s light years beyond a paper system.”
PowerBANK Enterprise Edition also supports the United States industry consensus standard for the uniform labeling of blood and blood components using ISBT 128 by using bar coded entry.
About Eclipsys
Eclipsys is a leading provider of advanced integrated information software, clinical content and professional services that help healthcare organizations improve clinical, financial, operational and customer- satisfaction outcomes. For more information, see www.eclipsys.com or email info@eclipsys.com.
Statements in this news release concerning the benefits provided by Eclipsys software are forward-looking statements and actual results may differ from those projected due to a variety of risks and uncertainties. Implementation and customization of Eclipsys software is complex and time- consuming. Results depend upon a variety of factors and can vary by client. Each client’s circumstances are unique and may include unforeseen issues that make it more difficult than anticipated to implement or derive benefit from software. The success and timeliness of the company’s services will depend at least in part upon client involvement, which can be difficult to control. Eclipsys is required to meet specified performance standards, and the contract can be terminated or its scope reduced under certain circumstances. More information about company risks is available in recent Form 10-Q and 10-K filings made by Eclipsys from time to time with the Securities and Exchange Commission. Special attention is directed to the portions of those documents entitled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Eclipsys Corporation and The Outcomes Company are registered trademarks of Eclipsys Corporation. Sunrise, Sunrise Laboratory, and PowerBANK Enterprise Edition are trademarks of Eclipsys Corporation. Other product and company names in this news release are trademarks and/or registered trademarks of their respective companies.
Eclipsys Jason Cigarran Robert J. Colletti Director of Media Relations (media) Chief Financial Officer (investors) jason.cigarran@eclipsys.com investor.relations@eclipsys.com (561) 322-4355
Source: Eclipsys
